🇺🇸 FDA
Patent

US 11479774

Methods of treating cancer harboring hemizygous loss of TP53

granted A61KA61K31/7088A61K31/7105

Quick answer

US patent 11479774 (Methods of treating cancer harboring hemizygous loss of TP53) held by The Board of Regents of the University of Texas System expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7088, A61K31/7105, A61K45/06, A61K47/6831